SCHEMBL4563362

SCHEMBL4563362

CCc1cnc(-c2ncccc2C)n1-c1ccc(Cl)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.38
CYP2A6 P11509 1/20 0.38
SMO Q99835 4/20 0.37
CACNA2D1 P54289 1/20 0.37
CYP1A2 P05177 3/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
PDE4B Q07343 1/20 0.37
PDE4D Q08499 1/20 0.37
GAA P10253 1/20 0.37
PTGS2 P35354 2/20 0.36
METAP2 P50579 1/20 0.35
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
HPGD P15428 1/20 0.35
CASP1 P29466 1/20 0.35
BRCA1 P38398 1/20 0.35
CASP7 P55210 1/20 0.35
HBB P68871 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4433247 0.73 CNR1 (0.45) TRPV1PDE4BPDE4DMEN1KMT2A
SCHEMBL4563433 0.72 KMT2A (0.50) MEN1KMT2APOLB
SCHEMBL10094698 0.69 TRPV1 (0.64) TRPV1CYP2A6GAAMETAP2HPGD
SCHEMBL3683921 0.68 KMT2A (0.52) GAAMEN1HPGDKMT2APOLB
SCHEMBL4562967 0.66 CNR1 (0.44) MEN1KMT2APOLB
SCHEMBL12857748 0.64 IDO1 (0.51) CYP1A2CYP3A4CYP2C9CYP2C19PDE4B
SCHEMBL29924154 0.64 CYP2A6 (0.61) TRPV1CYP2A6GAAMETAP2MEN1
SCHEMBL196235 0.64 CYP2A6 (0.61) TRPV1CYP2A6GAAMETAP2MEN1
SCHEMBL31252534 0.64 CYP2A6 (0.61) TRPV1CYP2A6GAAMETAP2MEN1
SCHEMBL196840 0.63 CYP2A6 (0.49) TRPV1CYP2A6SMOPTGS2METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2026798-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING CBX CANNABINOID RECEPTOR MODULATORS AND POTASSIUM CHANNEL MODULATORS Solvay Pharmaceuticals GmbH (DE) 2009-02-25 EP disclosed
WO-2007125048-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING CBX CANNABINOID RECEPTOR MODULATORS AND POTASSIUM CHANNEL MODULATORS SOLVAY PHARMACEUTICALS GMBH (DE) 2007-11-08 WO disclosed